InvestSMART

Monash IVF Group Limited (ASX: MVF) - Announcements

Current share price for MVF : $0.695 0.005 (0.71%)+

ASX company news and announcements for Monash IVF Group Limited (MVF) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Monash IVF Group Limited (MVF) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Monash IVF Group Limited (MVF), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Monash IVF Group Limited (MVF)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$271 Ceasing to be a substantial holder 6 Jun 2024 4:44PM $1.350 $0.695 fallen by 48.52%
$271 Becoming a substantial holder 23 May 2024 4:47PM $1.430 $0.695 fallen by 51.40%
$271 Ceasing to be a substantial holder from CGF 17 May 2024 4:29PM $1.465 $0.695 fallen by 52.56%
$271 Notification regarding unquoted securities - MVF 2 May 2024 5:27PM $1.460 $0.695 fallen by 52.40%
$271 Notification of release of shares held in escrow 2 May 2024 3:06PM $1.465 $0.695 fallen by 52.56%
$271 Response to ASX Query 1 May 2024 2:30PM $1.455 $0.695 fallen by 52.23%
$271 Change of Director's Interest Notice 29 Apr 2024 6:36PM $1.465 $0.695 fallen by 52.56%
$271 Notification of Release of Restricted Shares in Escrow 28 Mar 2024 12:25PM $1.455 $0.695 fallen by 52.23%
$271 Fertility North completion 4 Mar 2024 8:53AM $1.440 $0.695 fallen by 51.74%
$271 S&P DJI Announces March 2024 Quarterly Rebalance 1 Mar 2024 5:03PM $1.440 $0.695 fallen by 51.74%
$271 Initial Director's Interest Notice 26 Feb 2024 9:52AM $1.425 $0.695 fallen by 51.23%
$271 Non-executive Director Appointment - Ms Cathy Aston 26 Feb 2024 9:30AM $1.425 $0.695 fallen by 51.23%
$271 1H24 Results Presentation 23 Feb 2024 8:46AM $1.450 $0.695 fallen by 52.07%
$271 MVF delivers strong revenue and earnings growth 23 Feb 2024 8:30AM $1.450 $0.695 fallen by 52.07%
$271 Dividend/Distribution - MVF 23 Feb 2024 8:24AM $1.450 $0.695 fallen by 52.07%
$271 1H24 Appendix 4D and Financial Report 23 Feb 2024 8:23AM $1.450 $0.695 fallen by 52.07%
$271 AXX: Monash IVF's acquisition of Fertility North not opposed 22 Feb 2024 9:23AM $1.450 $0.695 fallen by 52.07%
$271 Notification of release of restricted shares in escrow 13 Feb 2024 2:12PM $1.458 $0.695 fallen by 52.32%
$271 Notification of Release of Shares held in Escrow 18 Jan 2024 1:51PM $1.330 $0.695 fallen by 47.74%
$271 MVF acquires Fertility North, expanding further in WA 19 Dec 2023 8:19AM $1.350 $0.695 fallen by 48.52%
$271 Ceasing to be a substantial holder 4 Dec 2023 4:59PM $1.310 $0.695 fallen by 46.95%
$271 Change of Director's Interest Notice 1 Dec 2023 2:22PM $1.303 $0.695 fallen by 46.64%
$271 Notification regarding unquoted securities - MVF 1 Dec 2023 2:19PM $1.300 $0.695 fallen by 46.54%
$271 MVF 2023 AGM Results 28 Nov 2023 3:46PM $1.275 $0.695 fallen by 45.49%
$271 2023 AGM - Presentation 28 Nov 2023 1:16PM $1.265 $0.695 fallen by 45.06%

101 - 125 of 487 results

Page 5 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.